Masimo (NASDAQ:MASI) is set to give its latest ... indicating a potential 57.12% upside. Peers Comparative Analysis Summary The peer analysis summary offers a detailed examination of key metrics ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo ...

It was hard to miss CoCo Vandeweghe’s commercial for the Masimo MightySat during Indian Wells. The 30-second ad for the newly released fingertip pulse oximeter played on nearly every changeover.

The $250 (yep, there’s no missing ‘M’ from the end of that number) Apple was awarded in its patent infringement case against Masimo might seem amusing – as John Gruber wryly noted ...

Masimo stock jumped Wednesday after Chief Executive Joe Kiani resigned, while the company's other executives stayed on board.

Masimo’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 14.63%. Image Source: Zacks Investment Research Let’s delve deeper.

Piper Sandler raised the firm’s price target on Masimo (MASI) to $180 from $165 and keeps an Overweight rating on the shares. The firm notes the company announced Q3 revenue of $505M finished ...

In its first earnings report since the departure of longtime CEO Joe Kiani, Masimo said Tuesday it is focused on reducing spending to drive long-term growth. The company continues to evaluate ...

Masimo MASI is set to give its latest quarterly ... indicating a potential 57.12% upside. The peer analysis summary offers a detailed examination of key metrics for Glaukos, Penumbra and Inspire ...